India  
 
NewsR.in

Johns Hopkins To Begin Blood Plasma Trials For Treatment Of COVID-19

Video Credit: Wochit News - Duration: 00:32s - Published
Johns Hopkins To Begin Blood Plasma Trials For Treatment Of COVID-19

Johns Hopkins To Begin Blood Plasma Trials For Treatment Of COVID-19

Johns Hopkins University will begin two clinical trials of convalescent blood plasma to treat COVID-19 next week.

Convalescent blood plasma is plasma derived from the blood of COVID-19 survivors.

According to UPI, researchers said the trials will focus on healthcare workers and nursing home residents.

Researchers theorize that the blood from recovered patients contains antibodies that may fight the virus.

Doctors hope that treatment will cut down on the need to hospitalize patients.


You Might Like


Related videos from verified sources

Trials underway for coronavirus plasma treatment [Video]

Trials underway for coronavirus plasma treatment

A clinical trial into the use of convalescent plasma therapy for COVID-19 patients is underway, with London identified as a key location by NHS Blood and Transplant. Report by Connerv. Like us on..

Credit: ODN     Duration: 01:36Published
Hospital first in Thailand to treat cure Covid-19 patient with blood plasma [Video]

Hospital first in Thailand to treat cure Covid-19 patient with blood plasma

hospital in southern Thailand has become the first in the country to successfully treat a Covid-19 sufferer using blood plasma from a recovered patient. The Prince of Songkhla hospital in Songkhla..

Credit: Newsflare     Duration: 02:03Published
Johns Hopkins' lost baseball season [Video]

Johns Hopkins' lost baseball season

Baseball is in Bob Babb’s blood. The Johns Hopkins University head coach of 41 years has seen it all. At least he thought he had.

Credit: ABC 2 News WMAR     Duration: 02:27Published